- Zodiac's Sweetened Bid: $0.84 per share, a 27% premium over recent trading price.
- Shareholder Support for Zodiac: Over 16% of shareholders (nearly 9 million shares) have tendered their shares to the initial offer.
- DXLG's Q1 2026 Performance: Revenue declined by 2.1%, net loss widened to $5.9 million, and comparable sales fell by 3.8%.
Experts would likely conclude that Zodiac’s all-cash offer presents a compelling short-term exit for shareholders, while the proposed merger with Full Beauty Brands carries significant financial risks and strategic uncertainties.
DXLG at a Crossroads: Zodiac's Sweetened Bid Forces a Board Reckoning
WEST PALM BEACH, FL – June 23, 2026 – The battle for control of Destination XL Group, Inc. (DXLG) has escalated into a high-stakes drama of corporate pressure and shareholder dissent. Zodiac Partners II, LLC, an activist investor, today intensified its pursuit of the big-and-tall men's retailer by increasing its all-cash tender offer to $0.84 per share. The sweetened bid is a direct challenge to DXLG’s board, which finds itself in the unenviable position of simultaneously fending off a hostile takeover while publicly admitting its own preferred merger with Full Beauty Brands (FBB) may no longer be in the best interest of shareholders.
This latest move by Zodiac, which includes a commitment of additional equity and an extension of the offer deadline to July 24, is more than a simple price adjustment; it is a calculated maneuver designed to corner the DXLG board. With over 16% of shareholders already signaling their support by tendering their shares to the initial offer, Zodiac is betting that a guaranteed cash payout will look increasingly attractive compared to the complex and risky all-stock merger the board has been championing.
A Tale of Two Offers
Shareholders of Destination XL are now faced with two vastly different paths. Zodiac’s revised offer is a model of simplicity: an all-cash payment of $0.84 per share, representing a roughly 27% premium to the stock's recent trading price. It offers a clean, immediate exit for investors in a company navigating significant headwinds. “We are pleased by the response from DXL’s stockholders, and by raising our price and committing additional capital we are demonstrating just how serious we are about completing this transaction,” said Ziggy Gokea, Managing Member of Zodiac Partners, in a statement that underscored the firm's confidence.
In stark contrast stands the proposed “merger of equals” with Full Beauty Brands. Announced in late 2025, the all-stock transaction was intended to create a $1.2 billion powerhouse in the inclusive-size apparel market. The deal would see FBB shareholders take a 55% controlling stake in the combined entity, with FBB’s CEO taking the helm. However, the industrial logic of the merger is now being overshadowed by its financial structure. Zodiac has relentlessly attacked the deal as a “highly levered, all-stock transaction” that would burden DXLG with FBB’s debt in an uncertain economic climate.
Critically, the DXLG board seems to be tacitly agreeing. In a stunning admission earlier this month, the board announced it was re-evaluating the merger terms, citing the “increasingly challenging consumer environment” and “FullBeauty's indebtedness” as reasons why the existing agreement was no longer in shareholders' best interests. This public expression of doubt has severely weakened the board’s position and provided Zodiac with the perfect opening to press its advantage.
The Hidden Costs of a Retail Revival
Beneath the surface of this corporate battle lies the difficult reality of DXLG’s operational health. The company is not in a death spiral, but it is clearly struggling. First-quarter results for 2026 revealed a 2.1% decline in revenue and a widening net loss of $5.9 million. Comparable sales, a key metric of retail health, fell by 3.8% as in-store traffic weakened. While the company holds no debt and has access to a $70 million credit facility, the persistent decline in sales paints a picture of a business fighting against a strong tide of reduced discretionary spending.
More alarming for the long-term view are emerging existential threats. Management has acknowledged the potential impact of new GLP-1 weight-loss drugs, which could, over time, shrink the company’s core customer base. This creates a significant, if unquantifiable, risk to the retailer's future revenue model. It is against this backdrop of declining performance and future uncertainty that the two offers must be judged. Zodiac’s bid provides a definitive value today. The FBB merger, on the other hand, asks shareholders to trade their current stock for shares in a new, more heavily indebted company whose strategic synergies and cost savings of $25 million are years away and far from guaranteed.
A Board Boxed In
The DXLG board now finds itself in a strategic box. Having unanimously recommended shareholders reject Zodiac’s initial offer in May as “highly conditional and opportunistic,” its own subsequent actions have undermined that stance. By questioning the FBB deal, the board has validated the very concerns Zodiac has been raising for weeks. This leaves them with little leverage in negotiations with either party.
Compounding the pressure is a fast-approaching leadership vacuum. DXLG’s President and CEO, Harvey Kanter, is set to retire on August 11, 2026. Zodiac has been quick to weaponize this fact, warning that if the board continues to pursue a faltering FBB deal, DXLG could be “left with no CEO, no transaction partner, and a diminished cash position” within weeks. The prospect of the business being “effectively orphaned,” as Zodiac puts it, is a powerful threat designed to force a decision.
Shareholder sentiment is the final, and perhaps most important, piece of the puzzle. The fact that nearly 9 million shares were tendered to Zodiac’s initial offer is a clear vote of no-confidence in the board’s strategy. It demonstrates a significant appetite among investors for the certainty of cash, and the board ignores this signal at its peril.
The Market's Verdict
Wall Street, for its part, remains deeply skeptical. On the day of Zodiac’s increased offer, DXLG’s stock traded below $0.70, significantly under the $0.84 bid price. This discount suggests that the market is not convinced any deal will successfully close. It is pricing in the risk that the FBB merger collapses without a Zodiac takeover to replace it, leaving DXLG to navigate a challenging retail environment with a retiring CEO and a board whose strategic credibility has been damaged.
The coming weeks will be decisive. The DXLG board must now respond to the sweetened offer, continue its fraught negotiations with Full Beauty Brands, and justify its path forward to an increasingly impatient shareholder base. For a company named Destination XL, the final destination has never been less certain.
